Concepedia

Alessia Melacarne

AM

6

Publications

287

Citations

6

H-Index

2014

Active since

Affiliations

Humanitas University(Current)

IRCCS Humanitas Research Hospital

University of Milan

European Institute of Oncology

Casa di Cura San Michele

Alessia Melacarne is an author at Humanitas University specializing in cell biology, immunology, and medicine.

ORCID

Top concepts

Publications per year

2014–2023

6

Publications

6

PARP14 Controls the Nuclear Accumulation of a Subset of Type I IFN–Inducible Proteins

Greta Caprara, Elena Prosperini, Viviana Piccolo et al. · The Journal of Immunology · 2018 · 97 citations

Paralysis of the cytotoxic granule machinery is a new cancer immune evasion mechanism mediated by chitinase 3-like-1

Abbass Darwich, Alessandra Silvestri, Mohamed-Reda Benmebarek et al. · Journal for ImmunoTherapy of Cancer · 2021 · 77 citations · Full text

, , +16

Sensitizing cancer cells to immune checkpoint inhibitors by microbiota-mediated upregulation of HLA class I

Valentina Ferrari, Antonino Lo Cascio, Alessia Melacarne et al. · Cancer Cell · 2023 · 43 citations · Full text

, , +9

SMAD Signaling Regulates CXCL12 Expression in the Bone Marrow Niche, Affecting Homing and Mobilization of Hematopoietic Progenitors

Satish Khurana, Alessia Melacarne, Rana Yadak et al. · Stem Cells · 2014 · 37 citations · Full text

, , +19

Identification of a class of non-conventional ER-stress-response-derived immunogenic peptides

Alessia Melacarne, Valentina Ferrari, Luca Tiraboschi et al. · Cell Reports · 2021 · 19 citations · Full text

Rows per page

1–5 of 6